Cargando…
CUL4B is a Potential Novel Prognostic Biomarker and is Correlated with Immune Infiltrates in Malignant Pleural Mesothelioma
BACKGROUND: Malignant pleural mesothelioma (MPM) is a particularly fatal cancer with a median survival of less than one year. The value of single-agent checkpoint inhibitors is still obscure in MPM. We aim to reveal CUL4B prognostic role and immune infiltrates in MPM patients. METHODS: CUL4B express...
Autores principales: | Liu, Lu, Hui, Ruting, Zeng, Tianyang, Yang, Xuetao, Wu, Qingchen, Yang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078356/ https://www.ncbi.nlm.nih.gov/pubmed/35535145 http://dx.doi.org/10.2147/IJGM.S355889 |
Ejemplares similares
-
Cul4A is an oncogene in malignant pleural mesothelioma
por: Hung, Ming-Szu, et al.
Publicado: (2011) -
Cul4A overexpression associated with Gli1 expression in malignant pleural mesothelioma
por: Yang, Yi-Lin, et al.
Publicado: (2015) -
Matrix Metalloproteinases Polymorphisms as Prognostic Biomarkers in Malignant Pleural Mesothelioma
por: Štrbac, Danijela, et al.
Publicado: (2017) -
Circulating biomarkers in malignant pleural mesothelioma
por: Viscardi, Giuseppe, et al.
Publicado: (2020) -
Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma
por: Ghanim, B, et al.
Publicado: (2014)